H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Census population 301,578. Missouri Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed St. Louis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a St. Louis storefront.
Skin Substitute Therapy Products in St. Louis, MO for clinics & physicians. Skin substitute therapy for co… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that St. Louis is J5 (WPS Government Health Administrators) and that adult diabetes here is 13.2% (PLACES 2023), it is selling units, not a program. That is the skin substitute therapy conversation we actually have.
National Skin Substitute Therapy Products notes (how the product actually works)Three grains, kept separate on purpose. City: Census 301,578 and CDC PLACES crude rates. State: Missouri Department of Health & Senior Services, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and WPS Government Health Administrators LCDs. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the skin substitute therapy account.
CDC PLACES (2023, crude prevalence) estimates 13.2% of adults — 1.2 points above the U.S. 12% figure. Obesity is 36.8%; arthritis is 24.2%. That is place-level BRFSS modeling, not a clinic census and not a St. Louis trial.
Missouri is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Missouri.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow WPS Government Health Administrators CTP articles. Mixing those codes is a billing error.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in St. Louis, MO.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for St. Louis is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for St. Louis — 1.2 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Missouri Part B wound biologics follow this contractor (siblings: IA, KS, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in St. Louis. Useful for joint-program math; still needs a diagnosis and privileging.
No St. Louis storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.